ACM
Americafirst Capital Management Portfolio holdings
AUM
$74M
This Quarter Return
+4.48%
1 Year Return
+13.49%
3 Year Return
+32.91%
5 Year Return
–
10 Year Return
–
AUM
$120M
AUM Growth
+$120M
(-22%)
Cap. Flow
-$32.5M
Cap. Flow
% of AUM
-26.99%
Top 10 Holdings %
Top 10 Hldgs %
15.48%
Holding
293
New
69
Increased
5
Reduced
43
Closed
70
Top Buys
| 1 |
LNCE
Snyders-Lance, Inc.
LNCE
|
$1.95M |
| 2 |
PDLI
PDL BioPharma, Inc.
PDLI
|
$1.85M |
| 3 |
AngioDynamics
ANGO
|
$1.81M |
| 4 |
Molson Coors Class B
TAP
|
$1.81M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$1.8M |
Top Sells
| 1 |
Lumen
LUMN
|
$3.55M |
| 2 |
Centene
CNC
|
$3.22M |
| 3 |
UGI
UGI
|
$3.09M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$3.04M |
| 5 |
CPN
Calpine Corporation
CPN
|
$2.57M |
Sector Composition
| 1 | Healthcare | 31.5% |
| 2 | Consumer Staples | 26.16% |
| 3 | Technology | 5.07% |
| 4 | Financials | 4.52% |
| 5 | Consumer Discretionary | 2.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cal-Maine
CALM
$5.61B
| $2.04M | 1.69% | 52,806 -478 | -0.9% | -$18.4K |
|
|
LNCE
2
DELISTED
Snyders-Lance, Inc.
LNCE
| $1.95M | 1.62% | +58,028 | New | +$1.95M |
|
3
Nu Skin
NUS
$602M
| $1.94M | 1.61% | 29,917 -34,642 | -54% | -$2.24M |
|
|
PDLI
4
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.85M | 1.54% | +551,804 | New | +$1.85M |
|
5
Merck
MRK
$210B
| $1.83M | 1.52% | 29,346 +27,358 | +1,376% | +$1.71M |
|
|
6
AngioDynamics
ANGO
$417M
| $1.81M | 1.51% | +103,451 | New | +$1.81M |
|
|
7
Molson Coors Class B
TAP
$9.98B
| $1.81M | 1.51% | +16,510 | New | +$1.81M |
|
8
Pfizer
PFE
$141B
| $1.81M | 1.5% | 53,352 -9,024 | -14% | -$306K |
|
|
HRC
9
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.8M | 1.5% | +29,028 | New | +$1.8M |
|
10
Zimmer Biomet
ZBH
$21B
| $1.79M | 1.49% | +13,755 | New | +$1.79M |
|
11
Edgewell Personal Care
EPC
$1.12B
| $1.79M | 1.48% | +22,459 | New | +$1.79M |
|
12
Universal Corp
UVV
$1.39B
| $1.78M | 1.48% | +30,494 | New | +$1.78M |
|
13
CONMED
CNMD
$1.68B
| $1.77M | 1.47% | +44,187 | New | +$1.77M |
|
14
Bio-Rad Laboratories Class A
BIO
$8.06B
| $1.76M | 1.46% | +10,760 | New | +$1.76M |
|
15
Abbott
ABT
$231B
| $1.76M | 1.46% | +41,599 | New | +$1.76M |
|
16
Fresh Del Monte Produce
FDP
$1.74B
| $1.76M | 1.46% | +29,366 | New | +$1.76M |
|
17
Owens & Minor
OMI
$378M
| $1.76M | 1.46% | +50,547 | New | +$1.76M |
|
18
Mondelez International
MDLZ
$79.5B
| $1.74M | 1.45% | +39,663 | New | +$1.74M |
|
19
Tyson Foods
TSN
$20.2B
| $1.74M | 1.45% | +23,291 | New | +$1.74M |
|
20
Baxter International
BAX
$12.7B
| $1.73M | 1.44% | +36,319 | New | +$1.73M |
|
21
Medtronic
MDT
$119B
| $1.72M | 1.43% | +19,962 | New | +$1.72M |
|
|
ALR
22
DELISTED
Alere Inc
ALR
| $1.72M | 1.43% | +39,801 | New | +$1.72M |
|
23
J&J Snack Foods
JJSF
$2.17B
| $1.71M | 1.42% | +14,370 | New | +$1.71M |
|
24
Hain Celestial
HAIN
$162M
| $1.71M | 1.42% | +48,084 | New | +$1.71M |
|
25
Tootsie Roll Industries
TR
$2.93B
| $1.71M | 1.42% | +46,310 | New | +$1.71M |
|